INCYTE JAPAN ANNOUNCES APPROVAL OF MINJUVI® (TAFASITAMAB) IN COMBINATION WITH RITUXIMAB AND LENALIDOMIDE FOR THE TREATMENT OF RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA

Reuters · 3d ago

Please log in to view news